ThuLEP vs. HoLEP vs. Monopolar Enucleation in Management of BPH
Comparative Analysis of the Efficacy and Safety of Thulium-fiber Laser Enucleation, Ho:YAG Laser Enucleation and Monopolar Enucleation in Management of BPH
1 other identifier
interventional
450
0 countries
N/A
Brief Summary
Today, endoscopic enucleation of the prostate (EEP) has been recognized a method of choice for treatment of benign prostatic hyperplasia (BPH) of any size, including large-sized glands (\>80 cc). The goal of our study was to compare perioperative efficacy, functional outcomes and safety of different techniques of endoscopic enucleation of the prostate (monopolar enucleation, holmium laser enucleation, thulium laser enucleation) in a single center.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2015
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 15, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 22, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
July 21, 2017
CompletedFirst Submitted
Initial submission to the registry
July 24, 2017
CompletedFirst Posted
Study publicly available on registry
July 26, 2017
CompletedJuly 28, 2017
July 1, 2017
2.3 years
July 24, 2017
July 26, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
IPSS
International Prostate Symptom Score
Six months
Secondary Outcomes (4)
QoL
Six months
PVR
Six months
Qmax
Six months
IIEF-5
Six months
Study Arms (3)
ThuLEP group
ACTIVE COMPARATORPatients who underwent thulium-fiber laser enucleation of the prostate due to lower urinary tract symptoms caused by prostatic hyperplasia.
Monopolar enucleation group
ACTIVE COMPARATORPatients who underwent monopolar enucleation of the prostate due to lower urinary tract symptoms caused by prostatic hyperplasia.
HoLEP group
ACTIVE COMPARATORPatients who underwent Ho:YAG laser enucleation of the prostate due to lower urinary tract symptoms caused by prostatic hyperplasia.
Interventions
A high-power (120 W) thulium fiber laser (Urolase, IPG IRE-POLUS, Russia) with wavelength of 1940 nm was used for thulium laser enucleation. In our study, we used a 600-μm laser fiber. The operations were performed at power of 60 W energy of 1.5 J and repetition rate of 40 Hz. Laser power in the verumontanum zone was decreased to 30 W and repetition rate to 20 Hz.
Monopolar enucleation was performed with a high-frequency generator (50-60 Hz), a pusher-electrode, and a hook-electrode.
Holmium laser enucleation of prostatic hyperplasia was performed with a 100 W laser (VersaPulse Powersuite 100, Lumenis, USA/Israel) with wavelength of 2100 nm and 550-μm fiber at the tip. The operation was performed at power of 70 W; it was decreased to 40 W when incisions were made at the verumontanum.
Eligibility Criteria
You may qualify if:
- IPSS\>20;
- maximum urinary flow rate\< 10ml\\s (Qmax);
- ineffective alfa-blockers therapy.
You may not qualify if:
- histologically verified prostate cancer;
- history of prostatic surgery;
- urethral strictures;
- bladder stones;
- chronic urinary retention and cystostomy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (3)
Gratzke C, Bachmann A, Descazeaud A, Drake MJ, Madersbacher S, Mamoulakis C, Oelke M, Tikkinen KAO, Gravas S. EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms including Benign Prostatic Obstruction. Eur Urol. 2015 Jun;67(6):1099-1109. doi: 10.1016/j.eururo.2014.12.038. Epub 2015 Jan 19.
PMID: 25613154BACKGROUNDCornu JN, Ahyai S, Bachmann A, de la Rosette J, Gilling P, Gratzke C, McVary K, Novara G, Woo H, Madersbacher S. A Systematic Review and Meta-analysis of Functional Outcomes and Complications Following Transurethral Procedures for Lower Urinary Tract Symptoms Resulting from Benign Prostatic Obstruction: An Update. Eur Urol. 2015 Jun;67(6):1066-1096. doi: 10.1016/j.eururo.2014.06.017. Epub 2014 Jun 25.
PMID: 24972732BACKGROUNDGlybochko PV, Rapoport LM, Enikeev ME, Enikeev DV. Holmium laser enucleation of the prostate (HoLEP) for small, large and giant prostatic hyperplasia: tips and tricks. Urologia. 2017 Aug 1;84(3):169-173. doi: 10.5301/uj.5000232. Epub 2017 May 10.
PMID: 28497447BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dmitry Enikeev, MD, PhD
I.M. Sechenov First Moscow State Medical University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Deputy Director for Sсience, Dept. of Urology, I.M. Sechenov Moscow State Medical University
Study Record Dates
First Submitted
July 24, 2017
First Posted
July 26, 2017
Study Start
January 15, 2015
Primary Completion
April 22, 2017
Study Completion
July 21, 2017
Last Updated
July 28, 2017
Record last verified: 2017-07
Data Sharing
- IPD Sharing
- Will not share